A-Alpha Bio

Seattle, United States

A-Alpha Bio uses synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions.

May 2024

Grant

Top Investors

Lux CapitalMadronaBill & Melinda Gates FoundationPerceptive AdvisorsBreakout Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are A-Alpha Bio's investors?

A-Alpha Bio's investors include Lux Capital, Madrona, Bill & Melinda Gates Foundation, Perceptive Advisors, Breakout Ventures.

Where is A-Alpha Bio headquartered?

A-Alpha Bio is headquartered in Seattle, United States.

What does A-Alpha Bio do?

A-Alpha Bio uses synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions.

What stage is A-Alpha Bio at?

A-Alpha Bio is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 21, 2024.

MLA

"A-Alpha Bio — Funding & Investors." VCBacked, May 21, 2024, https://www.vcbacked.co/company/a-alpha-bio. Accessed July 1, 2026.

APA

VCBacked. (2024). A-Alpha Bio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/a-alpha-bio

Wikipedia (cite web)

{{cite web |title=A-Alpha Bio — Funding & Investors |url=https://www.vcbacked.co/company/a-alpha-bio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 21, 2024.